Page last updated: 2024-11-12

sudachitin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sudachitin: antimicrobial from the peels of Citrus sudachi; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
CitrusgenusA plant genus of the family RUTACEAE. They bear the familiar citrus fruits including oranges, grapefruit, lemons, and limes. There are many hybrids which makes the nomenclature confusing.[MeSH]RutaceaeA plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH]

Cross-References

ID SourceID
PubMed CID12443122
CHEMBL ID479233
CHEBI ID175611
SCHEMBL ID6361479
MeSH IDM0501918

Synonyms (23)

Synonym
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,8-dimethoxychromen-4-one
CHEBI:175611
ACON1_000404
MEGXP0_000725
ACON0_001011
c18h16o8
NCGC00169109-01
CHEMBL479233
LMPK12111472
sudachitin
menthokubanone
4',5,7-trihydroxy-3',6,8-trimethoxyflavone
bdbm50412274
SCHEMBL6361479
4281-28-1
menthocubanone
5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,8-dimethoxy-4h-1-benzopyran-4-one
DTXSID701318467
flavone, 4',5,7-trihydroxy-3',6,8-trimethoxy-
6,8-dimethoxy-2-(3-methoxy-4-oxidanyl-phenyl)-5,7-bis(oxidanyl)chromen-4-one
4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,8-dimethoxy-
sudachinin
N9B4S6SPF5

Research Excerpts

Overview

Sudachitin is a PMF enriched in Citrus sudachi, and its functions and mechanism of action are poorly understood. It possesses antioxidant properties and regulates various functions in mammalian cells.

ExcerptReferenceRelevance
"Sudachitin is a PMF enriched in Citrus sudachi, and its functions and mechanism of action are poorly understood."( The Polymethoxyflavone Sudachitin Modulates the Circadian Clock and Improves Liver Physiology.
Burish, MJ; Chen, Z; Koike, N; Mawatari, K; Miura, H; Nii, Y; Nohara, K; Shikishima, Y; Shimohata, T; Takahashi, A; Uebanso, T; Wirianto, M; Yagita, K; Yoo, SH, 2023
)
1.94
"Sudachitin, which is a polymethoxylated flavonoid found in the peel of Citrus sudachi, has some biological activities. "( The Polymethoxy Flavonoid Sudachitin Inhibits Interleukin-1
Hosokawa, I; Hosokawa, Y; Matsuo, T; Ozaki, K, 2021
)
2.36
"Sudachitin, which is a polymethoxyflavone derived from Citrus sudachi, possesses antioxidant properties and regulates various functions in mammalian cells."( The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.
Hakeda, Y; Ito, J; Kitano, VJ; Ohyama, Y; Shimada, J, 2018
)
1.5
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
etherAn organooxygen compound with formula ROR, where R is not hydrogen.
flavonoidsAny organic molecular entity whose stucture is based on derivatives of a phenyl-substituted 1-phenylpropane possessing a C15 or C16 skeleton, or such a structure which is condensed with a C6-C3 lignan precursors. The term is a 'superclass' comprising all members of the classes of flavonoid, isoflavonoid, neoflavonoid, chalcones, dihydrochalcones, aurones, pterocarpan, coumestans, rotenoid, flavonolignan, homoflavonoid and flavonoid oligomers. Originally restricted to natural products, the term is also applied to synthetic compounds related to them.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)4.46680.00041.877310.0000AID342547
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID378071Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL at 100 ug/disk after 24 hrs by disk diffusion method2006Journal of natural products, Aug, Volume: 69, Issue:8
Chemical constituents from the peels of Citrus sudachi.
AID342547Inhibition of rat lens aldose reductase2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
QSAR prediction of inhibition of aldose reductase for flavonoids.
AID378075Antimicrobial activity against Helicobacter pylori ATCC 43504 at 100 ug/disk after 4 days by disk diffusion method2006Journal of natural products, Aug, Volume: 69, Issue:8
Chemical constituents from the peels of Citrus sudachi.
AID378073Antimicrobial activity against methicillin-resistant Staphylococcus aureus 5 at 100 ug/disk after 24 hrs by disk diffusion method2006Journal of natural products, Aug, Volume: 69, Issue:8
Chemical constituents from the peels of Citrus sudachi.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's7 (53.85)24.3611
2020's4 (30.77)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.80 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]